“I don't try to time the exact bottom; I watch when spot bid is real, when put premiums spike to ridiculous levels, and when price sits above the 200-week EMA where systematic strategies rebalance. Macro still drives the big move, but those three together are when I lean in.”
“I don't time the market. When we launched Ugly Unicorn in 2022, we ran a four-to-six-month test portfolio first because I knew most day traders blow out their accounts, and I'd rather miss the top than be the one calling it.”
“I stopped trying to nail the perfect entry years ago because my timing was mid, and it cost me less to admit that than to keep proving it. Now I hinge on research and ladder in as price drops, so bad timing actually lowers my average instead of wrecking me.”
“I don't time the market; I time the process. The Schwab study I keep coming back to showed that the investor who waited for the perfect entry finished behind the one who invested at the worst possible peak every year, because cash is the most expensive strategy in a compounding portfolio.”
“I don't time the market; I size the position around what the model says and what I can afford to lose if the model is wrong. Crypto in particular taught me that being directionally right but poorly sized is the same as being wrong.”
“I stopped trying to time Bitcoin tops and bottoms years ago; for family offices, the right entry is usually a small allocation, around 2%, when the infrastructure and custody are in place, not when the chart looks perfect.”
“I don't time markets as a strategy, but after 30 years I can usually feel when things are way oversold or way overbought. I scale in using tranches, nibbling when others panic and trimming when they get greedy, because timing is everything but perfect timing is a myth.”
“I spent years trying to time entries with gut and headlines, and the cost was a portfolio that looked smart in conversation but underperformed on the scorecard. Now I let a composite model tell me where to look, then I underwrite the specific business before I buy. The model does not time the market; it times when the weight of evidence has shifted enough that research is more likely to pay off.”
“I spent three years on Bridgewater's core management team watching macro timing eat alive people who thought they could call tops and bottoms. In development finance we learned the same thing: uncertainty is the enemy of capital deployment, so you size the position for the policy horizon, not the price chart.”